These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4633502)

  • 1. [The incidence of primary and secondary resistance to anti-tuberculous drugs].
    Schriever O
    Prax Pneumol; 1973 Mar; 27(3):145-9. PubMed ID: 4633502
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary drug resistance of Mycobacterium tuberculosis to antitubercular drugs and its clinical significance].
    Ianovskaia OM; Poliakova AN; Samuliak ID; Vasilik GV
    Probl Tuberk; 1975; (11):69-71. PubMed ID: 815904
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of resistance of tuberculous bacteriae to antibacterial drugs during the course of in vitro passages].
    Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1969; 33(3):349-80. PubMed ID: 4986399
    [No Abstract]   [Full Text] [Related]  

  • 4. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. 2].
    Yamamoto M
    Kekkaku; 1970 Nov; 45(11):359-66. PubMed ID: 4992936
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis.
    Kothadia SN; Sengupta SR
    Indian J Chest Dis Allied Sci; 1984; 26(3):163-6. PubMed ID: 6443608
    [No Abstract]   [Full Text] [Related]  

  • 6. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. Influence of background factors, factors regarding the method of treatment and the course of the disease on the emergence of drug resistance].
    Yamamoto M; Nakamura H; Inagaki H
    Kekkaku; 1970 Oct; 45(10):349-57. PubMed ID: 4991618
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary and secondary resistance of Mycobacterium tuberculosis to the primary antitubercular agents in the demonstration area of the SFRJ].
    Perak M
    Tuberkuloza; 1967; 19(5):505-11. PubMed ID: 4971781
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary resistance of tubercle bacillus to standard drugs (incidence in Recife)].
    Magalhães M
    Rev Bras Med; 1969 Jul; 26(7):395-7. PubMed ID: 4981470
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inoculability and drug resistance of Mycobacterium tuberculosis in patients with peripheral tuberculous lymphadenitis].
    Maskeev KM; Sidorkina EV; Krivtsova AE; Kim D; Eretina NG
    Probl Tuberk; 1971; 49(8):81-5. PubMed ID: 5005005
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary anti-tuberculosis drugs. II: resistant typical mycobacterium tuberculosis, unclassified mycobacteria.
    J Kans Med Soc; 1968 Nov; 69(11):534-6 concl. PubMed ID: 4972834
    [No Abstract]   [Full Text] [Related]  

  • 11. [Resistance to antitubercular drugs in strains of Mycobacterium tuberculosis isolated in Spain].
    Ausina Ruiz V; Lonca Giménez J
    Rev Clin Esp; 1999 Mar; 199(3):121-5. PubMed ID: 10230288
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary resistance to antitubercular drugs].
    Caminero Luna JA
    Med Clin (Barc); 1989 Jun; 93(1):30-6. PubMed ID: 2505005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Standards and methods for the examination of drug resistance of secondary antitubercular agents].
    Kekkaku; 1968 Mar; 43(3):47-8. PubMed ID: 4971119
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A; Mase M; Yamamoto M; Nakamura H
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary drug resistance of Mycobacterium tuberculosis to antituberculosis drugs.
    Safi MI; Zai S
    J Pak Med Assoc; 1988 Mar; 38(3):73-4. PubMed ID: 3133501
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of various combinations of antitubercular agents on the course of experimental tuberculous infections and development of drug resistance].
    Durisić M; Davidović C; Jovanović M; Marković Lj
    Glas Srp Akad Nauka Med; 1975; (26):17-23. PubMed ID: 816709
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary resistance of Mycobacterium tuberculosis in Brazil].
    de Lima Filho MT; de Oliveira AG; Nishi I; Saraiva LG; de Melo FA
    AMB Rev Assoc Med Bras; 1980 Jun; 26(6):182-4. PubMed ID: 6781015
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pattern of capreomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H
    Kekkaku; 1968 May; 43(5):161-4. PubMed ID: 4971952
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary resistance of Mycobacterium tuberculosis].
    Barranquero Arola M; Gorritxo Gil B; Goiriena de Gandarias J
    Rev Sanid Hig Publica (Madr); 1984; 58(11-12):1107-15. PubMed ID: 6443589
    [No Abstract]   [Full Text] [Related]  

  • 20. [Time factors in the so-called primary resistance of Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Ginesu F; Mancini P; Termine A
    Lotta Tuberc; 1972; 42(1):3-14. PubMed ID: 4626199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.